ENDO Yasuyuki | Faculty of Pharmaceutical Sciences, The University of Tokyo
スポンサーリンク
概要
関連著者
-
ENDO Yasuyuki
Faculty of Pharmaceutical Sciences, The University of Tokyo
-
SHUDO Koichi
Faculty of Pharmaceutical Sciences, The University of Tokyo
-
Shudo Koichi
Graduate School Of Pharmaceutical Sciences The University Of Tokyo
-
Shudo Koichi
Faculty Of Pharmaceutical Science Kyushu University
-
Shudo K
Research Foundation Itsuu Laboratory
-
Endo Yasuyuki
Faculty Of Pharmaceutical Sciences Tohoku Pharmaceutical University
-
遠藤 泰之
東北薬科大学薬学部
-
Itai Akiko
Insitute Of Medicinal Molecular Design Key Molecular Inc.
-
TAKEHANA Shunji
Faculty of Pharmaceutical Sciences, University of Tokyo
-
YAMAGUCHI Mitsuhiro
Faculty of Pharmaceutical Sciences, University of Tokyo
-
Yamaguchi M
Gifu Pharmaceutical University
-
Fujiki H
Saitama Cancer Center
-
Fujiki Hirota
Laboratory Of Biochemistry Faculty Of Pharmaceutical Sciences Tokushima Bunri University
-
山口 雅久
Fuji-gotemba Research Laboratories Chugai Pharmaceutical Company Ltd.
-
Takehana Shunji
Faculty Of Pharmaceutical Sciences University Of Tokyo
-
ITAI Akiko
Institute of Medicinal Molecular Design, Inc
-
FUKASAWA Hiroshi
Graduate School of Pharmaceutical Sciences, The University of Tokyo
-
HASHIMOTO Yuichi
Institute of Molecular & Cellular Biosciences, The University of Tokyo
-
Shitaka Mayuko
Faculty Of Pharmaceutical Sciences The University Of Tokyo
-
MATSUO Atsushi
Institute of Medicinal Molecular Design
-
MIZUTANI Miho
Institute of Medicinal Molecular Design
-
TOMIOKA Nobuo
Institute of Medicinal Molecular Design
-
Tomioka N
Insitute Of Medicinal Molecular Design Key Molecular Inc.
-
Mizutani Miho
Insitute Of Medicinal Molecular Design Key Molecular Inc.
-
FUJIKI Hirota
Saitama Cancer Center Research Institute
-
Kato Yuichi
Faculty of Pharmaceutical Sciences, University of Tokyo
-
Itai Akiko
Faculty of Pharmaceutical Sciences, University of Tokyo
-
Fujiki Hirota
National Cancer Center Research Institute
-
IWASAKI Shigeo
Institute of Molecular and Cellular Biosciences, The University of Tokyo
-
SUEOKA Naoko
Saitama Cancer Center Research Institute
-
Hirano Masaaki
Faculty Of Pharmaceutical Sciences University Of Tokyo
-
AZUMA Akihiko
Institute of Molecular and Cellular Biosciences, University of Tokyo
-
OHNO Michihiro
Faculty of Pharmaceutical Sciences, University of Tokyo
-
DRIEDGER Paul
Procyon Pharmaceuticals, Inc.
-
STABEL Silvia
Max-Delbruck-Laboratorium
-
ANDO Yunike
Institute of Molecular & Cellular Biosciences, University of Tokyo
-
FUKASAWA Hiroshi
Faculty of Pharmaceutical Sciences, University of Tokyo
-
Itai Akiko
Institute Of Medicinal Molecular Design
-
SUGANUMA Masami
Saitama Cancer Center, Research Institute for Clinical Oncology
-
Komori Atsumasa
Saitama Cancer Center Research Institute
-
Fukasawa Hiroshi
Graduate School Of Pharmaceutical Sciences The University Of Tokyo
-
Matsuo Atsushi
Institute For Materials Research Tohoku University
-
OKABE Sachiko
Saitama Cancer Center Research Institute
-
Iwasaki S
Institute Of Molecular And Cellular Biosciences The University Of Tokyo
-
Ando Yunike
Institute Of Molecular & Cellular Biosciences University Of Tokyo
-
Okabe S
Kyoto Pharmaceutical Univ. Kyoto Jpn
-
Sueoka Naoko
Saitama Cancer Center
-
Driedger Paul
Procyon Pharmaceuticals Inc.
-
Azuma Akihiko
Institute Of Molecular And Cellular Biosciences University Of Tokyo
-
Fujiki Hirota
Saitama Cancer Center
-
Ohno Michihiro
Faculty Of Pharmaceutical Sciences University Of Tokyo
-
Fukasawa H
Graduate School Of Pharmaceutical Sciences The University Of Tokyo
-
Sugihara M
Saitama Cancer Center Saitama Jpn
-
Iwasaki S
Univ. Tokyo Tokyo
-
Kato Yuichi
Faculty Of Pharmaceutical Sciences University Of Tokyo
-
Suganuma Masami
Research Institute For Clinical Oncology Saitama Cancer Center
-
Iwasaki Shigeo
Institute Of Molecular And Cellular Biosciences (imcb) The University Of Tokyo
-
Y.Mizutani Miho
Institute of Medicinal Molecular Design
-
Okabe Sachiko
Saitama Cancer Center
-
IWASAKI Shigeo
Institute of Molecular and Cellular Bioscience, The University of Tokyo
-
Itai Akiko
Faculty of Pharmaceutical Sciences, The University of Tokyo
-
SUGANUMA Masami
Saitama Cancer Center
著作論文
- ADVANCED COMPUTATIONAL DOCKING OF TWO TELEOCIDIN CONGENERS TO CYS2 DOMAIN OF PROTEIN KINASE Cδ
- Pd2 SUPERPOSITION OF TELEOCIDINS AND PHORBOL ESTERS BY A NEW COMPUTATIONAL METHOD
- ROLE OF THE HYDROPHOBIC MOIETY OF TUMOR PROMOTERS. SYNTHESIS AND ACTIVITY OF BENZOLACTAMS WITH ALKYL SUBSTITUENTS AT VARIOUS POSITIONS
- Photoaffinity Labeling of Tumor Promoter-Binding Protein (CN-TPBP) and Preparation of Affinity Sorbent Gels
- ROLE OF THE HYDROPHOBIC MOIETY OF TUMOR PROMOTERS. SYNTHESIS AND ACTIVITY OF 9-ALKYLATED BENZOLACTAMS
- Twist Form of Teleocidin Derivatives is Active in in Vivo Tumor Promotion by (-)-Benzolactam-V8-310